{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:13:37Z","timestamp":1787789617005,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reporting adverse drug reactions (ADRs) is fundamental in improving medication safety. Community pharmacists (CPs) being the first point of contact for individuals seeking healthcare in a community, play a significant role in ADR reporting. However, this has been poorly implemented in many countries including Nigeria. This paper aims to explore stakeholders\u2019 perspectives on current reporting practices and suggest ways to enhance ADR reporting among CPs in Nigeria. This qualitative study employed a purposive sampling approach to identify key informants. Key informant interviews (KIIs) were conducted with 25 carefully selected pharmacists, using a semi-structured interview guide between July 2023 and August 2023. The interview transcripts were analyzed using a thematic content approach. While a low ADR reporting trend was observed among all participating pharmacists, it was notably higher among those with less than five years of experience. The main barriers to ADR reporting, as identified by the interviewed community pharmacists were lack of awareness and knowledge, absence of motivation, and insufficient feedback from National Agency for Food Drug Administration and Control (NAFDAC). Training and awareness campaigns were the most frequently suggested methods for improving ADR reporting. Other proposed strategies included providing motivation, regular feedback, establishing mandatory reporting, and simplifying the reporting process. The study has highlighted the suboptimal ADR reporting practices among CPs in Anambra state. It underscores the significance of training, sensitization, advocacy, and other related interventions as pivotal means to enhance ADR reporting in this group. Furthermore, there is a pressing need for intervention-based studies to delve into and implement these approaches effectively.<\/jats:p>","DOI":"10.1038\/s41598-024-67263-8","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:02:02Z","timestamp":1721682122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country"],"prefix":"10.1038","volume":"14","author":[{"given":"Sunday Odunke","family":"Nduka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka Omelebere","family":"Ibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Adamma","family":"Nwaodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chana Chapchet","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"67263_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.medcli.2019.08.007","volume":"154","author":"E Montan\u00e9","year":"2020","unstructured":"Montan\u00e9, E. & Santesmases, J. Adverse drug reactions. Med. Clin. 154, 178\u2013184 (2020).","journal-title":"Med. Clin."},{"key":"67263_CR2","doi-asserted-by":"crossref","unstructured":"Pourpak, Z., Fazlollahi, M. & Fattahi, F. Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects. Recent Pat. Inflam. Aller. Drug Disco. 2, 24\u201326 (2008).","DOI":"10.2174\/187221308783399289"},{"key":"67263_CR3","unstructured":"World Health Organisation (WHO). Safety of medicine: a guide to detecting and reporting adverse drug reaction, Geneva. https:\/\/www.who.int\/publications\/i\/item\/who-edm-qsm-2002-2 (2002)."},{"key":"67263_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo, M. T., Chalmers, L. & Curtain, C. M. Adverse-drug-reaction-related hospitalisations in developed and developing countries: A review of prevalence and contributing factors. Drug. Saf. 39, 847\u2013857 (2016).","journal-title":"Drug. Saf."},{"key":"67263_CR5","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1371\/journal.pone.0004439","volume":"4","author":"EC Davies","year":"2009","unstructured":"Davies, E. C. et al. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. Plos. One. 4, 4439\u20134512 (2009).","journal-title":"Plos. One."},{"key":"67263_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1472-6904-9-8","volume":"9","author":"M Brvar","year":"2009","unstructured":"Brvar, M., Fokter, N., Bunc, M. & Mozina, M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC. Clin. Pharmacol. 9, 49\u201357 (2009).","journal-title":"BMC. Clin. Pharmacol."},{"key":"67263_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","volume":"49","author":"K Fattinger","year":"2000","unstructured":"Fattinger, K. et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br. J. Clin. Pharmacol. 49, 158\u2013167 (2000).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"15","key":"67263_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou, J., Pomeranz, B. H. & Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 279(15), 1200\u20131205 (1998).","journal-title":"JAMA."},{"key":"67263_CR9","unstructured":"Daphne, ES. Severity of adverse drug reactions. MSD Manual Consumer Version. https:\/\/www.msdmanuals.com\/home\/drugs\/adverse-drug-reactions\/severity-of-adverse-drug-reactions (2023)."},{"issue":"19","key":"67263_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003437","volume":"95","author":"JP Mouton","year":"2016","unstructured":"Mouton, J. P. et al. Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa. Medicine (Baltimore). 95(19), e3437 (2016).","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"67263_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S1516-31802011000300006","volume":"129","author":"KA Oshikoya","year":"2011","unstructured":"Oshikoya, K. A., Chukwura, H., Njokanma, O. F., Senbanjo, I. O. & Ojo, I. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao. Paulo. Med. J. 129(3), 153\u2013164 (2011).","journal-title":"Sao. Paulo. Med. J."},{"key":"67263_CR12","doi-asserted-by":"crossref","unstructured":"Lillo-Le Lou\u00ebt, A., Le Beller, C., Baud, F., Vivien, B. & Jouffroy, R. Adverse drugs reactions (adr) suspected through phone triage and assessed by medically staffed ambulances: A pilot study. Am. J. Emerg. Med. 54, 172\u2013177 (2022).","DOI":"10.1016\/j.ajem.2022.02.011"},{"key":"67263_CR13","unstructured":"World Health Organization. Reporting and learning systems for medication errors: the role of pharmacovigilance centres. https:\/\/www.who.int\/publications\/i\/item\/9789241507943 (2014)."},{"issue":"4","key":"67263_CR14","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.14577","volume":"87","author":"DA Adedapo","year":"2021","unstructured":"Adedapo, D. A., Adedeji, W. A., Adedapo, I. A. & Adedapo, K. S. Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality. Br. J. Clin. Pharmacol. 87(4), 1878\u20131889 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"67263_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4314\/tjpr.v17i5.25","volume":"17","author":"JA Udoye","year":"2018","unstructured":"Udoye, J. A., Ozolua, R. I. & Nwokike, J. Assessment of the knowledge, attitude and practice of pharmacovigilance by pharmacists in two states in Southeastern Nigeria. Trop. J. Pharm. Res. 17(5), 937\u2013945 (2018).","journal-title":"Trop. J. Pharm. Res."},{"issue":"3","key":"67263_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/qshc.3.3.153","volume":"3","author":"N Barber","year":"1994","unstructured":"Barber, N., Smith, F. & Anderson, S. Improving quality of health care: The role of pharmacists. Qual. Health Care. 3(3), 153\u2013158 (1994).","journal-title":"Qual. Health Care."},{"issue":"8","key":"67263_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200810","volume":"13","author":"YK Avong","year":"2018","unstructured":"Avong, Y. K. et al. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV\/AIDS, Tuberculosis and Malaria: A prospective cohort study. Plos One. 13(8), e0200810 (2018).","journal-title":"Plos One."},{"key":"67263_CR18","unstructured":"World Health Organization (WHO). The importance of pharmacovigilance. Safety monitoring of medicinal products. https:\/\/www.who.int\/publications\/i\/item\/10665-42493 (2002)."},{"key":"67263_CR19","first-page":"54","volume":"51","author":"NO Bello","year":"2017","unstructured":"Bello, N. O. & Atunwa, S. A. Knowledge and practice of reporting of adverse drug reactions among community pharmacists in Ilorin, Nigeria. Niger. J. Pharm. 51, 54 (2017).","journal-title":"Niger. J. Pharm."},{"issue":"1","key":"67263_CR20","first-page":"1","volume":"3","author":"P Emeka","year":"2017","unstructured":"Emeka, P., Badger-Emeka, L., Madu, P. E. & Lorena, B. E. A study on the knowledge and barriers towards ADRS reporting among community pharmacists in Enugu and Nsukka areas, south-eastern Nigeria. Pharmacol. Toxicol. Biomed. Rep. 3(1), 1\u20136 (2017).","journal-title":"Pharmacol. Toxicol. Biomed. Rep."},{"issue":"1","key":"67263_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/pds.2021","volume":"20","author":"IA Oreagba","year":"2011","unstructured":"Oreagba, I. A., Ogunleye, O. J. & Olayemi, S. O. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south West Nigeria. Pharmacoepidemiol. Drug saf. 20(1), 30\u201335 (2011).","journal-title":"Pharmacoepidemiol. Drug saf."},{"key":"67263_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40290-018-0228-8","volume":"32","author":"CK Ogar","year":"2018","unstructured":"Ogar, C. K. et al. Pharmacovigilance rapid alert system for consumer reporting (prascor): A look at its quantitative contribution to spontaneous reporting in Nigeria from august 2012 to february 2017. Pharm. Med. 32, 131\u2013141 (2018).","journal-title":"Pharm. Med."},{"issue":"5","key":"67263_CR23","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s13187-021-01988-2","volume":"37","author":"J Holcomb","year":"2022","unstructured":"Holcomb, J., Ferguson, G. M., Sun, J., Walton, G. H. & Highfield, L. Stakeholder engagement in adoption, implementation, and sustainment of an evidence-based intervention to increase mammography adherence among low-income women. J. Cancer Educ. 37(5), 1486\u20131495 (2022).","journal-title":"J. Cancer Educ."},{"key":"67263_CR24","doi-asserted-by":"crossref","unstructured":"Motu\u2019apuaka, M. et al. Defining the benefits and challenges of stakeholder engagement in systematic reviews. Comp. Effec. Res. 5, 13\u201319 (2015)","DOI":"10.2147\/CER.S69605"},{"key":"67263_CR25","unstructured":"Emmanuel Igwenagu. States Population in Nigeria. (2021) https:\/\/nigerianinformer.com\/states-population-in-nigeria."},{"issue":"4","key":"67263_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1759-8893.2012.00100.x","volume":"3","author":"KP Osemene","year":"2012","unstructured":"Osemene, K. P., Ayeni, M. I. & Afolabi, M. O. The role of community pharmacists in monitoring adverse drug reactions in Nigeria. J. Pharm. Health Services Res. 3(4), 197\u2013204 (2012).","journal-title":"J. Pharm. Health Services Res."},{"issue":"3","key":"67263_CR27","first-page":"931","volume":"15","author":"E Cheema","year":"2017","unstructured":"Cheema, E., Haseeb, A., Khan, T. M., Sutcliffe, P. & Singer, D. R. Barriers to reporting of adverse drugs reactions: A cross sectional study among community pharmacists in united kingdom. Pharm. Pract. 15(3), 931\u2013935 (2017).","journal-title":"Pharm. Pract."},{"issue":"12","key":"67263_CR28","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/pds.4800","volume":"28","author":"ML Hughes","year":"2019","unstructured":"Hughes, M. L. & Weiss, M. Adverse drug reaction reporting by community pharmacists: The barriers and facilitators. Pharmacoepidemiol. Drug Saf. 28(12), 1552\u20131559 (2019).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"21","key":"67263_CR29","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.3390\/ijerph182111393","volume":"18","author":"PC S\u00e1nchez-Guardiola","year":"2021","unstructured":"S\u00e1nchez-Guardiola, P. C., Aguaded, R. E. & Rodr\u00edguez-Sabiote, C. Content validation of a semi-structured interview to analyze the management of suffering. Int. J. Environ. Res. Public Health. 18(21), 11393 (2021).","journal-title":"Int. J. Environ. Res. Public Health."},{"issue":"9","key":"67263_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203588","volume":"13","author":"NM Neke","year":"2018","unstructured":"Neke, N. M., Gadau, G. & Wasem, J. Policy makers\u2019 perspective on the provision of maternal health services via mobile health clinics in tanzania\u2014findings from key informant interviews. PLoS ONE. 13(9), e0203588 (2018).","journal-title":"PLoS ONE."},{"issue":"1","key":"67263_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24926\/iip.v13i1.4502","volume":"13","author":"MA Raza","year":"2022","unstructured":"Raza, M. A., Aziz, S., Noreen, M., Anjum, I. & Raza, S. M. A portrait of the pharmacy profession globally: Pharmacist universal professional identity and establishment of global pharmacy council. Innov. Pharm. 13(1), 1\u20134 (2022).","journal-title":"Innov. Pharm."},{"key":"67263_CR32","unstructured":"Learning Knowledge Vs. Skill: Practice. https:\/\/www.mentalhelp.net\/self-help\/learning-knowledge-vs-skill-practice\/ (2023)."},{"key":"67263_CR33","unstructured":"The importance of reporting adverse drug reactions.https:\/\/www.nationalhealthexecutive.com\/Health-Service-Focus\/the-importance-of-reporting-adverse-drug-reactions (2013)."},{"key":"67263_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/AMEP.S225208","volume":"11","author":"S Shrestha","year":"2020","unstructured":"Shrestha, S. et al. Workshop on adverse drug reaction reporting, pharmacovigilance and its implementation in cancer hospital in Nepal: An event report. Adv. Med. Educ. Pract. 11, 9\u201314 (2020).","journal-title":"Adv. Med. Educ. Pract."},{"issue":"1","key":"67263_CR35","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/ijerph19010413","volume":"19","author":"K Senkiewicz","year":"2021","unstructured":"Senkiewicz, K. et al. The importance of direct patient reporting of adverse drug reactions in the safety monitoring process. Int. J. Environ. Res. Public Health. 19(1), 413\u2013429 (2021).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"67263_CR36","unstructured":"Handling adverse drug reactions (adrs)\u2014NAFDAC [Internet]. https:\/\/www.nafdac.gov.ng\/our-services\/pharmacovigilance-post-market-surveillance\/report-adverse-drug-reaction\/ [cited 2023 May 20]."},{"issue":"1","key":"67263_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2125.2001.01306.x","volume":"51","author":"CF Green","year":"2001","unstructured":"Green, C. F., Mottram, D. R., Rowe, P. H. & Pirmohamed, M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br. J. Clin. Pharmacol. 51(1), 81\u201386 (2001).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"67263_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2125.2005.02504.x","volume":"60","author":"A Vallano","year":"2005","unstructured":"Vallano, A. et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br. J. Clin. Pharmacol. 60(6), 653\u2013658 (2005).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"67263_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/BMJ.316.7140.1295","volume":"316","author":"M Pirmohamed","year":"1998","unstructured":"Pirmohamed, M., Breckenridge, A. M., Kitteringham, N. R. & Park, K. Adverse drug reactions. BMJ. 316, 1295. https:\/\/doi.org\/10.1136\/BMJ.316.7140.1295 (1998).","journal-title":"BMJ."},{"key":"67263_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200932010-00002","volume":"32","author":"E Lopez-Gonzalez","year":"2009","unstructured":"Lopez-Gonzalez, E., Herdeiro, M. T. & Figueiras, A. Determinants of under-reporting of adverse drug reactions. Drug Saf. 32, 19\u201331 (2009).","journal-title":"Drug Saf."},{"issue":"1","key":"67263_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00002018-200932010-00007","volume":"32","author":"C Pedr\u00f3s","year":"2009","unstructured":"Pedr\u00f3s, C. et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians. Drug Saf. 32(1), 77\u201383 (2009).","journal-title":"Drug Saf."},{"issue":"2","key":"67263_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11096-008-9276-6","volume":"31","author":"G Vessal","year":"2009","unstructured":"Vessal, G., Mardani, Z. & Mollai, M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm. World Sci. 31(2), 183\u2013187 (2009).","journal-title":"Pharm. World Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67263-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67263-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67263-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T21:04:33Z","timestamp":1721682273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67263-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67263"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67263-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16821"}}